- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Biofrontera AG (B8FKn)
Biofrontera AG stock price live, this page displays ETR B8FKn stock exchange data. View the B8FKn premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Biofrontera AG real time stock price chart below.
What Is the Biofrontera AG Stock Price Today?
The Biofrontera AG stock price today is 2.420.
What Is the Stock Symbol for Biofrontera AG?
The stock symbol for Biofrontera AG is "B8FKn."
What Stock Exchange Does Biofrontera AG Trade On?
Biofrontera AG is listed and trades on the Xetra stock exchange.
Is Biofrontera AG a Good Stock to Buy?
Determining whether Biofrontera AG—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the B8FKn quote. (ISIN: DE000A4BGGM7)
What Is the Biofrontera AG Stock Price Today?
The Biofrontera AG stock price today is 2.420.
What Is the Stock Symbol for Biofrontera AG?
The stock symbol for Biofrontera AG is "B8FKn."
What Stock Exchange Does Biofrontera AG Trade On?
Biofrontera AG is listed and trades on the Xetra stock exchange.
Is Biofrontera AG a Good Stock to Buy?
Determining whether Biofrontera AG—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the B8FKn quote. (ISIN: DE000A4BGGM7)
2.420
+0.060(+2.54%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.400
2.440
52 wk Range
2.160
2.960
Earnings results expected in 13 days
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.4002.440
52 wk Range
2.1602.960
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
B8FKn Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Net income is expected to grow this year
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Neutral
Moving Averages
Sell
Earnings
Latest Release
Feb 25, 2026
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
Compare B8FKn to Peers and Sector
Metrics to compare | B8FKn | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipB8FKnPeersSector | |
|---|---|---|---|---|
P/E Ratio | −2.1x | 17.0x | −0.5x | |
PEG Ratio | −0.22 | −0.20 | 0.00 | |
Price/Book | 1.0x | 1.4x | 2.6x | |
Price / LTM Sales | 1.1x | 1.8x | 3.1x | |
Upside (Analyst Target) | - | 25.1% | 54.0% | |
Fair Value Upside | Unlock | 14.0% | 6.5% | Unlock |
Biofrontera AG, a biopharmaceutical company, engages in the research, development, and distribution of dermatological products and medical products in Germany, Spain, the United Kingdom, rest of Europe, the United States, and internationally. The company offers Ameluz and BF-RhodoLED lamp for the treatment of mild and moderate actinic keratoses on the face and scalp, field cancerization, and fatal squamous cell carcinoma. The company also provides RhodoLED XL lamp for the treatment of multiple interspersed lesions; and Belixos, a cosmetic product for irritated and sensitive skin. In addition, the company focus on photodynamic therapy (PDT) for the treatment of actinic keratosis and keratinocyte skin cancers, including basal cell carcinoma. The company has a license and supply agreement with Maruho Co., Ltd. Biofrontera AG was founded in 1997 and is headquartered in Leverkusen, Germany.
People Also Watch
FAQ
What Is the Biofrontera AG (B8FKn) Stock Price Today?
The Biofrontera AG stock price today is 2.420 EUR.
What Stock Exchange Does Biofrontera AG Trade On?
Biofrontera AG is listed and trades on the Frankfurt Stock Exchange.
What Is the Stock Symbol for Biofrontera AG?
The stock symbol for Biofrontera AG is "B8FKn."
What Is the Biofrontera AG Market Cap?
As of today, Biofrontera AG market cap is 14.710M EUR.
What Is Biofrontera AG's Earnings Per Share (TTM)?
The Biofrontera AG EPS (TTM) is -1.143.
When Is the Next Biofrontera AG Earnings Date?
Biofrontera AG will release its next earnings report on Jun 03, 2026.
From a Technical Analysis Perspective, Is B8FKn a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Biofrontera AG Stock Split?
Biofrontera AG has split 6 times.
How Many Employees Does Biofrontera AG Have?
Biofrontera AG has 74 employees.
What is the current trading status of Biofrontera AG (B8FKn)?
As of May 21, 2026, Biofrontera AG (B8FKn) is trading at a price of 2.420 EUR, with a previous close of 2.360 EUR. The stock has fluctuated within a day range of 2.400 EUR to 2.440 EUR, while its 52-week range spans from 2.160 EUR to 2.960 EUR.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.